# Study Of MK-0752 In Combination With Tamoxifen Or Letrozole to Treat Early Stage Breast Cancer

> **NCT00756717** · PHASE4 · COMPLETED · sponsor: **Loyola University** · enrollment: 22 (actual)

## Conditions studied

- Breast Cancer

## Interventions

- **DRUG:** MK-0752

## Key facts

- **NCT ID:** NCT00756717
- **Lead sponsor:** Loyola University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-02-14
- **Primary completion:** 2011-12-21
- **Final completion:** 2011-12-21
- **Target enrollment:** 22 (ACTUAL)
- **Last updated:** 2019-09-04

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00756717

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00756717, "Study Of MK-0752 In Combination With Tamoxifen Or Letrozole to Treat Early Stage Breast Cancer". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00756717. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*